[시장보고서]혈액 점도계 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

혈액 점도계 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Blood Viscometer Market Size, Share & Trends Analysis Report By Product, By Application (Clinical Diagnostics, Point-of-Care Testing ), By End Use, By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1888690

리서치사 : Grand View Research

발행일 : 2025년 11월

페이지 정보 : 영문 105 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,728,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,195,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,129,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

혈액 점도계 시장 요약

세계의 혈액 점도계 시장 규모는 2024년에 16억 2,000만 달러로 추정되며, 2033년까지 26억 3,000만 달러에 달할 것으로 예측됩니다.

2025-2033년 연평균 5.63% 성장할 것으로 예측됩니다. 임상 진단 기술의 발전, 심혈관 및 혈액 질환의 유병률 증가, 현장 진료 검사 기술의 보급 확대가 성장 전망을 지원하고 있습니다.

2023년 4월, Clinical Blood Rheology and Microcirculation 저널에 게재된 연구에서는 관상동맥 질환 환자의 혈액 유변학 및 산화 질소(NO) 수치를 조사했습니다. 그 결과, 높은 적혈구 응집과 낮은 NO 수치가 심장의 측부혈관이 제대로 발달하지 않는 것과 관련이 있는 것으로 나타났습니다. 혈액 점도 측정 기술의 혁신이 진행되어 최신 장비는 실시간 측정, 최소 시료량, 비뉴턴 유체에 대한 민감도 향상을 실현하고 있습니다. 이러한 발전으로 보다 정밀한 유변학 평가가 가능해져 당뇨병, 고점성 증후군, 혈전증 등의 진단 정확도가 향상되어 일상적인 임상 검사에서 활용 범위가 넓어지고 있습니다. 2022년 12월, 바이오메디컬 저널에 게재된 논문에서는 접지(지구 표면과의 직접 접촉)가 염증 감소, 심박수 안정화, 혈류 개선에 도움이 된다는 내용이 발표되었습니다. 이 연구는 제타 전위의 측정 가능한 개선을 확인했으며, 적혈구 응집 감소를 시사합니다. 이는 점도와 직접적으로 연관된 요인이며, 임상연구에서 그 모니터링이 중요합니다.

심혈관 질환, 빈혈, 응고 장애의 발생률이 증가함에 따라 정확한 점도 측정 툴에 대한 수요가 증가하고 있습니다. 이러한 질환은 혈류 특성의 변화를 동반하는 경우가 많기 때문에 환자 위험 평가, 치료 경과 관찰, 치료법 최적화를 위해 점도계의 사용이 증가하고 있습니다. 2025년 2월 세계보건기구(WHO)는 빈혈이 전 세계 유아의 40%, 임산부의 37%, 가임기 여성의 30%에 영향을 미칩니다고 보고했습니다.

분산형 신속 진단 솔루션으로의 전환에 따라 중환자실(ICU), 외래 진료소 등 진료 현장에서 즉각적인 결과를 제공하는 컴팩트하고 사용하기 쉬운 점도계에 대한 수요가 증가하고 있습니다. 이러한 추세는 질병의 조기 발견을 돕고, 맞춤형 의료에 부합하는 비용 효율적인 의료 제공을 촉진하여 시장 성장을 지속하고 있습니다. 2023년 10월, Journal of Applied Physics 저널에 게재된 연구에서는 자화 구와 플럭스 게이트 자력계를 사용하여 유체내 움직임을 추적하는 자기 낙하구식 점도계가 소개되었습니다. 이 시스템은 단 15ml의 시료로 200-3000cP 범위의 점도를 몇 초 만에 측정하여 3%의 정확도를 달성합니다.

지역별 대시보드
시장 규모, 예측, 동향 분석(2021-2033년)
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제8장 경쟁 구도

기업/경쟁 분류
벤더 구도
- 주요 기업의 시장 점유율 분석, 2024년
- Anton Paar GmbH
- RheoSense, Inc.
- Benson Viscometers-Clinical Viscometers
- Beijing Steellex Scientific Instrument Co., Ltd.
- Health Onvector
- KYOTO ELECTRONICS MANUFACTURING CO., LTD.
- A&D;Company, Limited
- AMETEK.Inc.
- Cannon Instrument Company.
- CSC Scientific Company, Inc.

KSA

영문 목차

영문목차

Blood Viscometer Market Summary

The global blood viscometer market size was estimated at USD 1.62 billion in 2024 and is projected to reach USD 2.63 billion by 2033, growing at a CAGR of 5.63% from 2025 to 2033. The growth outlook by advancements in clinical diagnostics, the increasing prevalence of cardiovascular and hematological disorders, and the growing adoption of point-of-care testing technologies.

In April 2023, a study published in Clinical Hemorheology and Microcirculation examined blood rheology and nitric oxide levels in coronary artery disease patients. The findings showed that higher erythrocyte aggregation and lower NO levels were linked to poorer collateral vessel development in the heart. Innovation in blood viscometry is increasing, with modern instruments offering real-time measurement, minimal sample volume requirements, and enhanced sensitivity for non-Newtonian fluids. These advancements enable more precise rheology assessments, improve diagnostic accuracy in conditions such as diabetes, hyperviscosity syndromes, and thrombosis, and expand use in routine clinical testing.In December 2022, an article in the Biomedical Journal discussed how grounding, or direct contact with the Earth's surface, helps lower inflammation, stabilize heart rate, and improve flow. The study noted measurable improvements in zeta potential, suggesting reduced red blood cell aggregation, a factor directly linked to viscosity and its monitoring in clinical research.

The rising incidence of cardiovascular diseases, anemia, and coagulation disorders is fueling demand for accurate viscosity measurement tools. As these disorders often involve changes in blood flow properties, viscometers are increasingly used for patient risk assessment, treatment monitoring, and therapy optimization.In February 2025, the World Health Organization (WHO) reported that anemia affects 40% of young children, 37% of pregnant women, and 30% of women of reproductive age worldwide.

The shift toward decentralized, rapid diagnostic solutions is driving demand for compact, user-friendly viscometers that deliver instant results in point-of-care settings, such as ICUs and outpatient clinics. This trend supports early disease detection, aligns with personalized medicine, and promotes cost-efficient healthcare delivery, sustaining market growth. In October 2023, a study in the Journal of Applied Physics presented a magnetic falling-sphere viscometer that employs a magnetized sphere and fluxgate magnetometers to track its motion through fluid. The system requires only 15 ml of sample and determines viscosities from 200 to 3000 cP within seconds, achieving 3% precision.

Global Blood Viscometer Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global blood viscometer market report based on product, application, end use, and region.

Product Outlook (Revenue, USD Million, 2021 - 2033)
Capillary Viscometer
Rotational Viscometer
Vibrational / Oscillatory Viscometer
Microfluidic Viscometer
Application Outlook (Revenue, USD Million, 2021 - 2033)
Clinical Diagnostics
Hematology & Blood Research
Point-of-Care Testing (POCT)
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals & Diagnostic Laboratories
Research & Academic Institutes
Pharmaceutical & Biotechnology Companies
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
  - 1.4.5.1. Data for primary interviews in North America
  - 1.4.5.2. Data for primary interviews in Europe
  - 1.4.5.3. Data for primary interviews in Asia Pacific
  - 1.4.5.4. Data for primary interviews in Latin America
  - 1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. End use outlook
- 2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Blood Viscometer Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Rising prevalence of cardiovascular and metabolic disorders
  - 3.2.1.2. Shift toward advanced point-of-care and research diagnostics
  - 3.2.1.3. Healthcare infrastructure expansion and private lab proliferation
- 3.2.2. Market restraint analysis
  - 3.2.2.1. High device cost and limited reimbursement support
  - 3.2.2.2. Lack of technical expertise and standardized protocols
- 3.2.3. Competitive factors and strategies
  - 3.2.3.1. Clinical insights
  - 3.2.3.2. Emerging technologies
  - 3.2.3.3. Market appeal
  - 3.2.3.4. Product improvements and innovations
3.3. Blood Viscometer Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape
3.4. Technology landscape
3.5. Regulatory Framework
3.6. Case Study Analysis

Chapter 4. Blood Viscometer Market: Product Estimates & Trend Analysis

4.1. Definition and Scope
4.2. Product Market Share Analysis, 2024 & 2033
4.3. Segment Dashboard
4.4. Capillary Viscometer
- 4.4.1. Capillary viscometer market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Rotational Viscometer
- 4.5.1. Rotational viscometer market estimates and forecasts 2021 to 2033 (USD Million)
4.6. Vibrational / Oscillatory Viscometer
- 4.6.1. Vibrational / oscillatory viscometer market estimates and forecasts 2021 to 2033 (USD Million)
4.7. Microfluidic Viscometer
- 4.7.1. Microfluidic viscometer market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Blood Viscometer Market: Application Estimates & Trend Analysis

5.1. Definition and Scope
5.2. Application Market Share Analysis, 2024 & 2033
5.3. Segment Dashboard
5.4. Clinical Diagnostics
- 5.4.1. Clinical diagnostics market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Hematology & Blood Research
- 5.5.1. Hematology & blood research market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Point-of-Care Testing (POCT)
- 5.6.1. Point-of-care testing (POCT) market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Blood Viscometer Market: End Use Estimates & Trend Analysis

6.1. Definition and Scope
6.2. End Use Market Share Analysis, 2024 & 2033
6.3. Segment Dashboard
6.4. Hospitals & Diagnostic Laboratories
- 6.4.1. Hospitals & diagnostic laboratories market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Research & Academic Institutes
- 6.5.1. Research & academic institutes market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Pharmaceutical & Biotechnology Companies
- 6.6.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Blood Viscometer Market: Regional Estimates & Trend Analysis by Product, Application and End Use

7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
7.3. North America
- 7.3.1. U.S.
  - 7.3.1.1. Key country dynamics
  - 7.3.1.2. Regulatory framework/ reimbursement structure
  - 7.3.1.3. Competitive scenario
  - 7.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
- 7.3.2. Canada
  - 7.3.2.1. Key country dynamics
  - 7.3.2.2. Regulatory framework/ reimbursement structure
  - 7.3.2.3. Competitive scenario
  - 7.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
- 7.3.3. Mexico
  - 7.3.3.1. Key country dynamics
  - 7.3.3.2. Regulatory framework/ reimbursement structure
  - 7.3.3.3. Competitive scenario
  - 7.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
7.4. Europe
- 7.4.1. UK
  - 7.4.1.1. Key country dynamics
  - 7.4.1.2. Regulatory framework/ reimbursement structure
  - 7.4.1.3. Competitive scenario
  - 7.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.2. Germany
  - 7.4.2.1. Key country dynamics
  - 7.4.2.2. Regulatory framework/ reimbursement structure
  - 7.4.2.3. Competitive scenario
  - 7.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.3. France
  - 7.4.3.1. Key country dynamics
  - 7.4.3.2. Regulatory framework/ reimbursement structure
  - 7.4.3.3. Competitive scenario
  - 7.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.4. Italy
  - 7.4.4.1. Key country dynamics
  - 7.4.4.2. Regulatory framework/ reimbursement structure
  - 7.4.4.3. Competitive scenario
  - 7.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.5. Spain
  - 7.4.5.1. Key country dynamics
  - 7.4.5.2. Regulatory framework/ reimbursement structure
  - 7.4.5.3. Competitive scenario
  - 7.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.6. Norway
  - 7.4.6.1. Key country dynamics
  - 7.4.6.2. Regulatory framework/ reimbursement structure
  - 7.4.6.3. Competitive scenario
  - 7.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.7. Sweden
  - 7.4.7.1. Key country dynamics
  - 7.4.7.2. Regulatory framework/ reimbursement structure
  - 7.4.7.3. Competitive scenario
  - 7.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.8. Denmark
  - 7.4.8.1. Key country dynamics
  - 7.4.8.2. Regulatory framework/ reimbursement structure
  - 7.4.8.3. Competitive scenario
  - 7.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Asia Pacific
- 7.5.1. Japan
  - 7.5.1.1. Key country dynamics
  - 7.5.1.2. Regulatory framework/ reimbursement structure
  - 7.5.1.3. Competitive scenario
  - 7.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.2. China
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Regulatory framework/ reimbursement structure
  - 7.5.2.3. Competitive scenario
  - 7.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.3. India
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Regulatory framework/ reimbursement structure
  - 7.5.3.3. Competitive scenario
  - 7.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.4. Australia
  - 7.5.4.1. Key country dynamics
  - 7.5.4.2. Regulatory framework/ reimbursement structure
  - 7.5.4.3. Competitive scenario
  - 7.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.5. South Korea
  - 7.5.5.1. Key country dynamics
  - 7.5.5.2. Regulatory framework/ reimbursement structure
  - 7.5.5.3. Competitive scenario
  - 7.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.6. Thailand
  - 7.5.6.1. Key country dynamics
  - 7.5.6.2. Regulatory framework/ reimbursement structure
  - 7.5.6.3. Competitive scenario
  - 7.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Latin America
- 7.6.1. Brazil
  - 7.6.1.1. Key country dynamics
  - 7.6.1.2. Regulatory framework/ reimbursement structure
  - 7.6.1.3. Competitive scenario
  - 7.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.2. Argentina
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Regulatory framework/ reimbursement structure
  - 7.6.2.3. Competitive scenario
  - 7.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
7.7. Middle East & Africa
- 7.7.1. South Africa
  - 7.7.1.1. Key country dynamics
  - 7.7.1.2. Regulatory framework/ reimbursement structure
  - 7.7.1.3. Competitive scenario
  - 7.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
- 7.7.2. Saudi Arabia
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Regulatory framework/ reimbursement structure
  - 7.7.2.3. Competitive scenario
  - 7.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 7.7.3. UAE
  - 7.7.3.1. Key country dynamics
  - 7.7.3.2. Regulatory framework/ reimbursement structure
  - 7.7.3.3. Competitive scenario
  - 7.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 7.7.4. Kuwait
  - 7.7.4.1. Key country dynamics
  - 7.7.4.2. Regulatory framework/ reimbursement structure
  - 7.7.4.3. Competitive scenario
  - 7.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

8.1. Company/Competition Categorization
8.2. Vendor Landscape
- 8.2.1. Key company market share analysis, 2024
- 8.2.2. Anton Paar GmbH
  - 8.2.2.1. Overview
  - 8.2.2.2. Financial Performance
  - 8.2.2.3. Product Benchmarking
  - 8.2.2.4. Strategic Initiatives
- 8.2.3. RheoSense, Inc.
  - 8.2.3.1. Overview
  - 8.2.3.2. Financial Performance
  - 8.2.3.3. Product Benchmarking
  - 8.2.3.4. Strategic Initiatives
- 8.2.4. Benson Viscometers - Clinical Viscometers
  - 8.2.4.1. Overview
  - 8.2.4.2. Financial Performance
  - 8.2.4.3. Product Benchmarking
  - 8.2.4.4. Strategic Initiatives
- 8.2.5. Beijing Steellex Scientific Instrument Co., Ltd.
  - 8.2.5.1. Overview
  - 8.2.5.2. Financial Performance
  - 8.2.5.3. Product Benchmarking
  - 8.2.5.4. Strategic Initiatives
- 8.2.6. Health Onvector
  - 8.2.6.1. Overview
  - 8.2.6.2. Financial Performance
  - 8.2.6.3. Product Benchmarking
  - 8.2.6.4. Strategic Initiatives
- 8.2.7. KYOTO ELECTRONICS MANUFACTURING CO., LTD.
  - 8.2.7.1. Overview
  - 8.2.7.2. Financial Performance
  - 8.2.7.3. Product Benchmarking
  - 8.2.7.4. Strategic Initiatives
- 8.2.8. A&D Company, Limited
  - 8.2.8.1. Overview
  - 8.2.8.2. Financial Performance
  - 8.2.8.3. Product Benchmarking
  - 8.2.8.4. Strategic Initiatives
- 8.2.9. AMETEK.Inc.
  - 8.2.9.1. Overview
  - 8.2.9.2. Financial Performance
  - 8.2.9.3. Product Benchmarking
  - 8.2.9.4. Strategic Initiatives
- 8.2.10. Cannon Instrument Company.
  - 8.2.10.1. Overview
  - 8.2.10.2. Financial Performance
  - 8.2.10.3. Product Benchmarking
  - 8.2.10.4. Strategic Initiatives
- 8.2.11. CSC Scientific Company, Inc.
  - 8.2.11.1. Overview
  - 8.2.11.2. Financial Performance
  - 8.2.11.3. Product Benchmarking
  - 8.2.11.4. Strategic Initiatives

한글목차

혈액 점도계 시장 요약

목차

제1장 조사 방법과 범위

제2장 개요

제3장 혈액 점도계 시장 변수, 동향 및 범위

제4장 혈액 점도계 시장 : 제품별 추정·동향 분석

제5장 혈액 점도계 시장 : 용도별 추정·동향 분석

제6장 혈액 점도계 시장 : 최종 용도별 추정·동향 분석

제7장 혈액 점도계 시장 : 지역별 추정·동향 분석